Dr. Mark Christiansen, MD
Claim this profileDiablo Clinical Research, Inc.
Studies Obesity
Studies Diabetes
7 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Mark Christiansen, MD is currently running
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
LY3305677
for Obesity
This trial is testing a new medication called LY3305677 to help adults who are obese or overweight manage their weight. The study will last over a year. Researchers want to see if this medication helps people lose weight and if it is safe to use.
Recruiting0 awards Phase 22 criteria
More about Mark Christiansen, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mark Christiansen, MD has experience with
- Standard Lifestyle Education
- Signos MHealth Platform
- 670G And 770G Insulin Pump
- Subject's Current Diabetes Therapy
- Volagidemab
- Insulin Efsitora Alfa
Breakdown of trials Mark Christiansen, MD has run
Diabetes
Type 1 Diabetes
Metabolic Syndrome
Weight Loss
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Christiansen, MD specialize in?
Mark Christiansen, MD focuses on Obesity and Diabetes. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Mark Christiansen, MD currently recruiting for clinical trials?
Yes, Mark Christiansen, MD is currently recruiting for 5 clinical trials in Walnut Creek California. If you're interested in participating, you should apply.
Are there any treatments that Mark Christiansen, MD has studied deeply?
Yes, Mark Christiansen, MD has studied treatments such as Standard Lifestyle Education, Signos mHealth Platform, 670G and 770G Insulin Pump.
What is the best way to schedule an appointment with Mark Christiansen, MD?
Apply for one of the trials that Mark Christiansen, MD is conducting.
What is the office address of Mark Christiansen, MD?
The office of Mark Christiansen, MD is located at: Diablo Clinical Research, Inc., Walnut Creek, California 94598 United States. This is the address for their practice at the Diablo Clinical Research, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.